The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...

Dr. Vinay Prasad, the new director of the FDA's Center for Biologics Evaluation and Research, explained that the changes aim ...

The Food and Drug Administration announced sweeping changes to its COVID-19 vaccine policy Tuesday, signaling a major ...

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

No, this is not true. Vaccines undergo rigorous safety testing and are continuously monitored for adverse events.

The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for certain ...

The requirement for placebo-controlled trials isn’t expected to affect the rollout this fall for older adults and other groups at high risk for severe illness.

The U.S. Food and Drug Administration (FDA) is set to significantly alter its approach to approving COVID-19 vaccines, a move ...

Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...

GENEVA (AP) — World Health Organization member countries on Tuesday approved an agreement to better prevent, prepare for and respond to future pandemics in the wake of the devastation wrought by the ...

The WHO's landmark Pandemic Agreement creates history as 194 nations unite to prevent future global health disasters through ...

US negotiators stepped away from the process after President Donald Trump initiated a formal withdrawal from the WHO upon ...